Skip to main content

Articles By Jack Cush, MD

Fracture%20bone.png (keep)

NY Times on Osteoporosis in Men

The NY Times has addressed the problem of osteoporosis in men noting a need for increased awareness and screening. Takeaways:

Read Article
PSA2L.jpg

Gender Complexities in Psoriatic Arthritis Treatment Outcomes

Analysis of a German psoriatic arthritis (PsA) patients registry demonstrates sex-specific differences regarding clinical manifestation and treatment outcomes, especially with regard to drug discontinuations.

Read Article
op.compare.jpg

Osteoporosis Screening in High-Risk Men

A Veterans Affairs (VA) Health Systems study of older male veterans found benefits of a remote model of screening that significantly improved osteoporosis screening, treatment, and adherence compared with usual care, with high patient and clinician acceptance.

Read Article
Stop%20Biologics%20green.png

Optimizing DMARD Therapy in Rheumatoid Arthritis

A phase IV trial from Spain demonstrates that optimization of therapy by lessening biological DMARDs in rheumatoid arthritis (RA) may be feasible, with a low risk of flare.

Read Article
RA Hands Difficult deformity

Not all difficult-to-treat RA will have rapid radiographic progression

A study of radiographic outcomes in difficult-to-treat rheumatoid arthritis (D2T RA) and poly-refractory RA (pr-RA) show a subset in whom damage is rapid and in need of more aggressive therapy.

Read Article
RheumNow Podcast square

Associations in Rheumatology (10.3.2025)

Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from the past week on RheumNow.com.

Read Article
Hip

Hip Osteoarthritis Treated with Exercise plus Weight Loss Diet

An exercise and diet intervention study showed that while exercise improved hip pain, adding a weight loss diet to exercise did not change hip pain but improve most secondary outcomes.

Read Article
FDA%20approved2.jpg

Guselkumab FDA Approved for Pediatric Psoriasis and Psoriatic Arthritis

FDA announced yesterday that guselkumab (Tremfya) is approved for use in pediatric patients moderate to severe plaque psoriasis (PsO) or active psoriatic arthritis (PsA) in children six years and older (weighing at least 40 kg).  

Read Article
lung.ILD.MD

Detection, Monitoring & Management of Autoimmune ILD

The American Journal of Managed Care has reviewed the approach to patients with interstitial lung disease (ILD); a significant cause of morbidity and mortality in those with systemic autoimmune rheumatic diseases (SARDs), including rheumatoid arthritis (RA), systemic sclerosis (SSc), and idiopath

Read Article
RheumNow Podcast square

How Does Your Garden Grow (9.26.2025)

Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Pool therapy, Fibrosis, NSIE's and what's best for knee OA. 

Read Article
×